Table 1 Patient characteristics
Characteristics | N = 28 (%) |
|---|---|
Age (years) | |
median | 66 (range: 50–80) |
Stage | |
De novo stage IV | 7 (25) |
recurrent disease | 21 (75) |
Subtype | |
HR+ HER2+ | 28 (100) |
others | 0 |
Number of treatment line | |
median | 6 |
1 or 2 | 6 (21) |
3–6 | 9 (32) |
7–10 | 9 (32) |
> 10 | 4 (14) |
Prior treatment for recurrent or metastatic breast cancer | |
Trastuzumab | 28 (100) |
Pertuzumab | 4 (14) |
T-DM1 | 10 (36) |
Trastuzumab deruxtecan (T-DXd) | 2 (7) |
Visceral metastasis | |
Yes | 21 (75) |
No | 7 (25) |
Liver metastasis | |
Yes | 11 (39) |
No | 17 (61) |
Brain metastasis | |
Yes | 4 (14) |
No | 24 (86) |